Clinical Value of Adding Dapagliflozin in Patients With Nephrotic Syndrome

Clinical trial NCT06026787 · COMPLETED

Trial details

NCT number: NCT06026787
Sponsor: Ain Shams University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Nephrotic Syndrome Sodium-Glucose Transporter 2 Inhibitors

Start date: 2022-08-01
Primary completion: 2023-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.